GSK3884464
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3884464, covering 2024-05-02 to 2024-05-02. Get the full timeline:
Most recent: Clinical Trial Update: A First Time in Human (FTIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK3884464 in Healthy Participants [Phase 1]